-
Electronic (PDF)
-
Site License
-
Enterprisewide
Competitor Analysis: Enzyme Replacement Therapies
La Merie Publishing, January 2013, Pages: 74
The Competitive Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies and of enzyme enhancement therapies to treat human genetic diseases/lysosomal storage diseases and exocrine pancreatic insufficiency due to cystic fibrosis, pancreatitis and other causes.
Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of novel enzyme replacement & enhancement therapy products and an overview of approved products. In addition, the report lists company-specific product portfolios and R&D pipelines of enzyme replacement and enhancement therapies. Competitor projects are listed in a tabular format providing Information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
1. Enzyme Replacement Therapies
Gaucher Disease 6
Fabry Disease 10
Pompé Disease 13
Hunter Disease (MPS II) 15
Niemann Pick Diseases 17
Mucopolysaccharidosis I (MPS I) 18
San Filippo Syndrome (MPS IIIA) 19
Morquio Syndrome (MPS IVA) 21
Mucopolysaccharidosis VI (MPS VI) 22
Tay-Sachs Disease 23
Chronic Deficiency of Adenosine Deaminase 24
Phenylketonuria / Hyperphenylalaninemia 25
Other Enzyme Replacement Therapies 26
Exocrine Pancreatic Insufficiency: Porcine-Derived ERT 31
Exocrine Pancreatic Insufficiency: Recombinant ERT 34
2. Corporate Enzyme Replacement Therapies R&D Pipelines
Abbott 36
Actelion 36
Alexion Pharmaceuticals 38
Amicus Therapeutics 38
AnGes MG 40
Angiochem 41
Aptalis Pharma 41
ArmaGen Technologies 42
Asubio Pharma 43
Axcan Pharma 44
BioMarin 44
Bionaturis 48
Dainippon Sumitomo Pharma 48
Digestive Care 49
Dong-A Pharmaceuticals 49
Eli LIlly 50
Eisai 50
Esteve 51
ExSar 52
GlaxoSmithKline (GSK) 53
Green Cross 55
Harvest Moon Pharmaceuticals 55
iBio, Inc. 56
ISU Abxis 56
JCR Pharmaceuticals 57
Johnson & Johnson 58
Kissei Pharmaceuticals 58
Lixte Biotechnology Holdings 59
Mayoly-Spindler 60
McNeil Consumer 61
Merck Serono 61
Nycomed 62
Orphan Technologies 62
Orphazyme 64
Protalix Biotherapeutic 64
Pfizer 66
Protea Biosciences 67
Recordati 67
ReGenX Biosciences 68
Sangamo Biosciences 69
Sanofi 69
Shire 72
Sigma-Tau 74
Specialty Pharmaceuticals 75
Swedish Orphan Biovitrum 75
Synageva 76
Ultragenyx Pharmaceutical 77
uniQure 77
Universitat Autónoma de Barcelona 78
Vivendy Therapeutics 78
Zymenex 79
- Abbott
- Actelion
- Alexion Pharmaceuticals
- Amicus Therapeutics
- AnGes MG
- Angiochem
- Aptalis Pharma
- ArmaGen Technologies
- Asubio Pharma
- Axcan Pharma
- BioMarin
- Bionaturis
- Dainippon Sumitomo Pharma
- Digestive Care
- Dong-A Pharmaceuticals
- Eli LIlly
- Eisai
- Esteve
- ExSar
- GlaxoSmithKline (GSK)
- Green Cross
- Harvest Moon Pharmaceuticals
- iBio, Inc
- ISU Abxis
- JCR Pharmaceuticals
- Johnson & Johnson
- Kissei Pharmaceuticals
- Lixte Biotechnology Holdings
- Mayoly-Spindler
- McNeil Consumer
- Merck Serono
- Nycomed
- Orphan Technologies
- Orphazyme
- Protalix Biotherapeutic
- Pfizer
- Protea Biosciences
- Recordati
- ReGenX Biosciences
- Sangamo Biosciences
- Sanofi
- Shire
- Sigma-Tau
- Specialty Pharmaceuticals
- Swedish Orphan Biovitrum
- Synageva
- Ultragenyx Pharmaceutical
- uniQure
- Universitat Autónoma de Barcelona
- Vivendy Therapeutics
- Zymenex
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
